Aditxt, Inc. (ADTX)

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Immune Reprogramming Technologies	645.18K	Log In	Log In
Immune Reprogramming Technologies Growth	-30.90%	Log In	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
United States	645.18K	Log In	Log In
United States Growth	-30.90%	Log In	Log In